[Leu144,Arg147]-PLP (139-151)

[Leu144,Arg147]-PLP (139-151) is a modified myelin proteolipid protein fragment that acts as a TCR antagonist, suppressing encephalitogenic Th1 clone activation in vitro and inhibiting experimental autoimmune encephalomyelitis (EAE) progression in vivo, making it a key tool for neuroimmunology and multiple sclerosis research.